Latest news
Barclays Downgrades REGENXBIO to Equalweight From Overweight, $12 Price Target - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 11:45:38 GMTARCOSA, INC. : STEPHENS CUTS TO EQUAL WEIGHT FROM OVERWEIGHT; RAISES TARGET PRICE TO $150 FROM $142 - BitgetBitget · Thu, 06 Aug 2026 20:29:15 GMTMorgan Stanley Downgrades Freshpet to Equalweight From Overweight, Adjusts PT to $72 From $77 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:51:50 GMTStephens Downgrades Southern Missouri Bancorp to Equalweight From Overweight - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:49:52 GMTCapital One Downgrades HubSpot to Equalweight From Overweight, Adjusts PT to $206 From $224 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:16:38 GMTStephens Downgrades HubSpot to Equalweight From Overweight, Adjusts PT to $251 From $249 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:15:34 GMTWells Fargo Downgrades Insulet to Equalweight From Overweight, Adjusts PT to $144 From $255 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 09:21:36 GMTWells Fargo Downgrades New Jersey Resources to Equalweight From Overweight, Adjusts Price Target to $61 From $63 - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 12:11:24 GMT